Keyphrases
Clinical Trials
100%
Research Trials
100%
Fibrolamellar Carcinoma
100%
Tumor
16%
Hepatocellular Carcinoma
16%
Surgical Resection
16%
Cirrhosis
16%
Targeted Therapy
16%
Multicenter Clinical Trial
16%
Amino
16%
Viral Agents
16%
Cyclic AMP-dependent Protein Kinase
16%
Older Adults
16%
Putative Drug Targets
16%
Oncogene
16%
Immune Defense
16%
Fusion Protein
16%
Standard of Care
16%
Chemical Agents
16%
Catalytic Subunit
16%
Systemic Therapy
16%
Potential Identification
16%
Novel Therapies
16%
Oncogenic Pathways
16%
Metabolic Drugs
16%
J-domain
16%
Co-chaperone
16%
Hepatic Cancer
16%
Heat Shock Protein 40
16%
Medicine and Dentistry
Carcinoma
100%
Clinical Trial
100%
Neoplasm
16%
Malignant Neoplasm
16%
Surgery
16%
Amino Terminal Sequence
16%
Immunotherapy
16%
Oncogene
16%
Liver Cirrhosis
16%
Targeted Therapy
16%
Systemic Therapy
16%
Cyclic AMP Dependent Protein Kinase
16%
Liver Cancer
16%
Adolescent
16%
Chemical Agent
16%
Enzyme Active Site
16%
Fusion Protein
16%
Chaperone
16%
Fibrolamellar Hepatocellular Carcinoma
16%
Heat Shock Protein 40
16%
Immunology and Microbiology
Immunotherapy
100%
Amino Terminal Sequence
100%
Enzyme Active Site
100%
Heat Shock
100%
Oncogene
100%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Carcinoma
100%
Neoplasm
16%
Malignant Neoplasm
16%
Immunotherapy
16%
Cyclic AMP Dependent Protein Kinase
16%
Chaperone
16%
Fusion Protein
16%
Liver Cancer
16%
Liver Cirrhosis
16%
Fibrolamellar Hepatocellular Carcinoma
16%
Heat Shock Protein 40
16%